Anders Fink-Jensen

Anders Fink-Jensen

Clinical Professor

Member of:

  • Psychiatry


  1. 2024
  2. Accepted/In press

    Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys

    Fink-Jensen, Anders, Wörtwein, Gitta, Klausen, M. K., Holst, Jens Juul, Hartmann, Bolette, Thomsen, M., Ptito, Maurice, Beierschmitt, A. & Palmour, R. M., 2024, (Accepted/In press) In: Psychopharmacology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis

    Kushner, R. F., Fink-Jensen, Anders, Frenkel, O., McGowan, B., Goldman, B., Overvad, M. & Wadden, T., 2024, In: Obesity. 32, 2, p. 273-280 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Accepted/In press

    I Didn’t Want the Psychotic Thing to Get Out to Anyone at All: Adolescents with Early Onset Psychosis Managing Stigma

    Klauber, D. G., Christensen, S. H., Fink-Jensen, Anders & Pagsberg, Anne Katrine, 2024, (Accepted/In press) In: Culture, Medicine and Psychiatry.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study

    Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, In: Acta Psychiatrica Scandinavica. 150, 1, p. 35-47 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Virtual reality-assisted cognitive behavioral therapy for patients with alcohol use disorder: a randomized feasibility study

    Thaysen-Petersen, D., Hammerum, S. K., Vissing, A., Oestrich, I. H., Nordentoft, Merete, Düring, S. W. & Fink-Jensen, Anders, 2024, In: Frontiers in Psychiatry. 15, 12 p., 1337898.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2023
  8. Published
  9. Published

    GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

    Leggio, L., Hendershot, C. S., Farokhnia, M., Fink-Jensen, Anders, Klausen, M. K., Schacht, J. P. & Simmons, W. K., 2023, In: Nature Medicine. 29, 12, p. 2993-2995 3 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  10. Published

    Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series

    Prasad, F., De, R., Korann, V., Chintoh, A. F., Remington, G., Ebdrup, Bjørn, Siskind, D., Knop, Filip Krag, Vilsbøll, Tina, Fink-Jensen, Anders, Hahn, M. K. & Agarwal, S. M., 2023, In: Therapeutic Advances in Psychopharmacology. 13, 10 p., 20451253231165169.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    The effectiveness of oxytocin for treating substance use disorders: A systematic review of randomized placebo-controlled trials

    Mellentin, A. I., Finn, S. W., Skøt, L., Thaysen-Petersen, D., Mistarz, N., Fink-Jensen, Anders & Nielsen, D. G., 2023, In: Neuroscience and Biobehavioral Reviews. 151, 16 p., 105185.

    Research output: Contribution to journalReviewResearchpeer-review

  12. Published

    The use of classic psychedelics among adults: a Danish online survey study

    Søgaard Juul, T., Ebbesen Jensen, M. & Fink-Jensen, Anders, 2023, In: Nordic Journal of Psychiatry. 77, 4, p. 367-378

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 916366